PBS Changes from 1 September 2025

Information relating to the new and amended Pharmaceutical Benefits Scheme (PBS) listings implemented on 1 September 2025 is available to download.

USANZ Members may be particularly interested in items related to:

• Stage IV renal cell carcinoma
  Cabozantinib (20 mg tablet; 40 mg tablet; 60 mg tablet) (Cabometyx®) no longer has a listing for Grandfather arrangements.

Download the PDF: PBS Listings 1 September 2025

This information relates to the administration of these listings by Services Australia. For further information, please download the Frequently Asked Questions. For information on broader PBS changes, please visit the PBS website. Relevant information and authority application forms have been updated and can be accessed through the Services Australia website.